These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16894114)

  • 21. Type of hip fracture in patients with Parkinson disease is associated with femoral bone mineral density.
    Di Monaco M; Vallero F; Di Monaco R; Tappero R; Cavanna A
    Arch Phys Med Rehabil; 2008 Dec; 89(12):2297-301. PubMed ID: 19061742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible association between acute pelvic inflammatory disease in pregnant women and congenital abnormalities in their offspring: a population-based case-control study.
    Acs N; Bánhidy F; Puhó EH; Czeizel AE
    Birth Defects Res A Clin Mol Teratol; 2008 Aug; 82(8):563-70. PubMed ID: 18553461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Association between estrogen receptor beta gene polymorphisms and Parkinson disease].
    Chen RJ; Zhang BS; Wang SM
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1185-8. PubMed ID: 18844113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between thyroid disease and its treatment with ANCA small-vessel vasculitis: a case-control study.
    Lionaki S; Hogan SL; Falk RJ; Joy MS; Chin H; Jennette CE; Jennette JC; Nachman PH
    Nephrol Dial Transplant; 2007 Dec; 22(12):3508-15. PubMed ID: 17686815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-inflammatory drugs and atherosclerosis.
    Moubayed SP; Heinonen TM; Tardif JC
    Curr Opin Lipidol; 2007 Dec; 18(6):638-44. PubMed ID: 17993809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glatiramer acetate could be a potential therapeutic agent for Parkinson's disease through its neuroprotective and anti-inflammatory effects.
    Tsai SJ
    Med Hypotheses; 2007; 69(6):1219-21. PubMed ID: 17548170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Professional exposure to pesticides and Parkinson disease.
    Elbaz A; Clavel J; Rathouz PJ; Moisan F; Galanaud JP; Delemotte B; Alpérovitch A; Tzourio C
    Ann Neurol; 2009 Oct; 66(4):494-504. PubMed ID: 19847896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
    Fukata M; Vamadevan AS; Abreu MT
    Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progress in the development of small molecule therapeutics targeting Th17 cell function for the treatment of immune-inflammatory diseases.
    Shuttleworth S; Townsend P; Silva F; Cecil A; Hill T; Tomassi C; Rogers H; Harrison R
    Prog Med Chem; 2011; 50():109-33. PubMed ID: 21315929
    [No Abstract]   [Full Text] [Related]  

  • 30. Association between caffeine intake and risk of Parkinson's disease among fast and slow metabolizers.
    Tan EK; Chua E; Fook-Chong SM; Teo YY; Yuen Y; Tan L; Zhao Y
    Pharmacogenet Genomics; 2007 Nov; 17(11):1001-5. PubMed ID: 18075470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
    Thorand B; Baumert J; Kolb H; Meisinger C; Chambless L; Koenig W; Herder C
    Diabetes Care; 2007 Apr; 30(4):854-60. PubMed ID: 17392546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New biological drugs for the treatment of chronic inflammatory diseases].
    Skov L; Hegedüs L; Madsbad S; Bendtzen K
    Ugeskr Laeger; 2008 Jun; 170(24):2162. PubMed ID: 18572482
    [No Abstract]   [Full Text] [Related]  

  • 33. Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration.
    Rosenkranz D; Weyer S; Tolosa E; Gaenslen A; Berg D; Leyhe T; Gasser T; Stoltze L
    J Neuroimmunol; 2007 Aug; 188(1-2):117-27. PubMed ID: 17582512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of antihypertensives and the risk of Parkinson disease.
    Becker C; Jick SS; Meier CR
    Neurology; 2008 Apr; 70(16 Pt 2):1438-44. PubMed ID: 18256367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.
    Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Tan EK; Drozdzik M
    Pharmacogenet Genomics; 2008 Sep; 18(9):815-21. PubMed ID: 18698234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiovascular complications in immune mediated diseases].
    Finckh A
    Rev Med Suisse; 2013 Mar; 9(377):549-50, 552, 554-5. PubMed ID: 23534241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parkinsonism in Caplan's syndrome.
    Rizzo G; Scaglione C; Lopane G; Pollini A; Tommasoni E; Martinelli P
    Neurol Sci; 2006 Apr; 27(1):67-9. PubMed ID: 16688603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experimental application of bucolome for inflammatory diseases in the urological field].
    Sugiura H; Shimaya M
    Hinyokika Kiyo; 1969 May; 15(5):375-81. PubMed ID: 5816788
    [No Abstract]   [Full Text] [Related]  

  • 39. [Bases and norms of utilization of anti-inflammatory drugs in dental surgery].
    Gregori C
    Ars Curandi Odontol; 1974; 1(3):26-30. PubMed ID: 4535569
    [No Abstract]   [Full Text] [Related]  

  • 40. Inflammation and allergy. Editorial.
    Tunctan B
    Antiinflamm Antiallergy Agents Med Chem; 2014 Mar; 13(1):1-2. PubMed ID: 24484207
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.